Hospital
Chattanooga Hamilton County Hospital Authority
Chattanooga Hamilton County Hospital Authority was paid $5.64M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
33Billing provider infoCHATTANOOGA HAMILTON COUNTY HOSPITAL AUTHORITY
PIKEVILLE, TN 37367
PIKEVILLE, TN 37367
33aNPI1770678617assigned 10/04/2006
33bProvider typeCritical Access Hospital
28Total paid$5.64M
24GClaims98,532
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Tennessee
Rank by total paid#2 of 15
Median peer was paid$1.48M
This provider vs. median3.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,258 | $669K | |
| 2019 | 15,998 | $697K | |
| 2020 | 11,683 | $703K | |
| 2021 | 18,350 | $1.07M | |
| 2022 | 20,465 | $1.22M | |
| 2023 | 14,585 | $973K | |
| 2024incomplete | 2,193 | $313K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 8,983 | 8,113 | $1.73M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 11,221 | 10,522 | $1.50M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 5,618 | 4,924 | $1.28M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 2,986 | 2,792 | $188K |
| 80053 | Comprehensive metabolic panel | 2.0% | 8,774 | 7,430 | $114K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 9,955 | 8,599 | $111K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 4,038 | 3,502 | $102K |
| 84484 | 1.2% | 3,146 | 1,864 | $66K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,250 | 1,936 | $54K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 225 | 194 | $50K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,656 | 2,402 | $49K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 786 | 752 | $40K |
48 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,995 | $38K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,903 | $32K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,793 | $32K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 188 | $27K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 715 | $24K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 788 | $24K |
| 85027 | <1% | 3,165 | $23K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,054 | $20K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 225 | $18K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,851 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 539 | $13K |
| 87430 | <1% | 740 | $13K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 25 | $12K |
| 81001 | <1% | 3,317 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,074 | $11K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 443 | $7K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 138 | $6K |
| 83735 | <1% | 780 | $6K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 91 | $5K |
| 81025 | <1% | 478 | $4K | |
| 83690 | <1% | 315 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 660 | $3K |
| 80061 | Lipid panel | <1% | 741 | $3K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 762 | $3K |
| 87040 | <1% | 273 | $2K | |
| 87081 | <1% | 122 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,018 | $2K |
| 81003 | <1% | 1,188 | $2K | |
| 80076 | <1% | 1,027 | $2K | |
| 83605 | <1% | 259 | $2K | |
| 82550 | <1% | 296 | $2K | |
| J3490 | Unclassified drugs | <1% | 2,441 | $1K |
| 85379 | <1% | 44 | $740.91 | |
| 96376 | <1% | 33 | $662.03 | |
| 71045 | Radiologic examination, chest; single view | <1% | 93 | $660.58 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 12 | $315.28 |
| 85730 | <1% | 50 | $195.71 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 448 | $188.09 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,023 | $187.15 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,184 | $119.29 |
| 85610 | <1% | 50 | $114.86 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $102.87 |
| 80047 | <1% | 35 | $26.54 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 401 | $23.42 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 27 | $17.43 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 39 | $0.00 |
| 80050 | General health panel | 0% | 18 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBREXLER, JAMES (PRESIDENT AND CEO)
| Provider | Location | Paid |
|---|---|---|
| Chattanooga Hamilton County Hospital Authority | Chattanooga, TN | $52.41M |
| Chattanooga Hamilton County Hospital Authority | Pikeville, TN | $6K |
| Chattanooga Hamilton County Hospital Authority | Chattanooga, TN | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.